2025
SJR Q3
JCR Q3 · 2,5
OA
18 matched articles
SCIE
Journal detail
Korean Journal of Physiology and Pharmacology
- Publisher
- Korean Physiological Soc. and Korean Soc. of Pharmacology
- Country
- South Korea · Asiatic Region
- Type
- journal
- ISSN
-
1226451220933827
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,606
- Quartile Q3
- H-Index 46
- Cites/doc 2,38
- Docs (3y) 153
- Cites (3y) 358
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,5
- 5Y JIF 2,3
- JCI 0,67
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Pharmacology Q3
- Physiology Q3
Areas
- Biochemistry, Genetics and Molecular Biology
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy | Physiology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q3 | 0,606 | 2,5 | 2,3 | 0,67 | Q2 | 46 |
| 2024 | Q3 | Q3 | 0,545 | 2,2 | 2,1 | 0,64 | Q3 | 43 |
| 2023 | Q3 | Q3 | 0,405 | 1,6 | 1,9 | 0,55 | Q3 | 43 |
| 2022 | Q3 | Q4 | 0,417 | 2 | 2 | 0,55 | Q3 | 43 |
| 2021 | Q3 | Q4 | 0,499 | 1,7 | 2,1 | 0,52 | Q3 | 43 |
| 2020 | Q3 | Q4 | 0,514 | 2 | 2 | 0,53 | Q3 | 43 |
| 2019 | Q3 | Q3 | 0,553 | 1,8 | 1,9 | 0,61 | Q3 | 43 |
| 2018 | — | Q4 | — | 1,7 | 1,8 | 0,57 | Q3 | — |
| 2017 | Q2 | Q4 | 0,727 | 1,5 | 1,6 | 0,62 | Q3 | 43 |
| 2016 | Q2 | Q3 | 0,68 | 2,1 | 1,6 | — | — | 43 |
| 2015 | Q2 | Q3 | 0,642 | 1,5 | 1,3 | — | — | 43 |
| 2014 | Q3 | Q3 | 0,569 | 1,4 | 1,3 | — | — | 43 |
| 2013 | Q3 | Q3 | 0,526 | 1,3 | 1,1 | — | — | 43 |
| 2012 | Q3 | Q4 | 0,427 | 1 | — | — | — | 43 |
| 2011 | Q3 | Q4 | 0,37 | 1 | — | — | — | 43 |
| 2010 | Q3 | Q4 | 0,185 | 0,5 | — | — | — | 43 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 205/356 |
| 2025 | PHYSIOLOGY | SCIE | Q3 | Q3 | 48/89 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 209/352 |
| 2024 | PHYSIOLOGY | SCIE | Q3 | Q3 | 48/87 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 259/354 |
| 2023 | PHYSIOLOGY | SCIE | Q4 | Q4 | 68/85 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 218/278 |
| 2022 | PHYSIOLOGY | SCIE | Q4 | Q4 | 61/79 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 242/279 |
| 2021 | PHYSIOLOGY | SCIE | Q4 | Q3 | 72/81 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 222/276 |
| 2020 | PHYSIOLOGY | SCIE | Q4 | Q4 | 64/81 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 211/271 |
| 2019 | PHYSIOLOGY | SCIE | Q3 | Q3 | 56/81 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 205/267 |
| 2018 | PHYSIOLOGY | SCIE | Q4 | Q3 | 65/81 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 214/261 |
| 2017 | PHYSIOLOGY | SCIE | Q4 | Q3 | 67/83 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 160/257 |
| 2016 | PHYSIOLOGY | SCIE | Q3 | — | 49/84 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 190/255 |
| 2015 | PHYSIOLOGY | SCIE | Q4 | — | 66/83 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 187/255 |
| 2014 | PHYSIOLOGY | SCIE | Q4 | — | 68/83 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 188/256 |
| 2013 | PHYSIOLOGY | SCIE | Q4 | — | 66/81 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 204/261 |
| 2012 | PHYSIOLOGY | SCIE | Q4 | — | 65/80 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 208/261 |
| 2011 | PHYSIOLOGY | SCIE | Q4 | — | 69/79 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 227/252 |
| 2010 | PHYSIOLOGY | SCIE | Q4 | — | 73/78 |